For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of Vyndamax and Attruby represents a true change. These innovative therapies preserve the transthyretin protein, preventing its damaging build-up and lessening the burden of the disease . People are now experiencing benefits in their… Read More